Laddar...
Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma
Bendamustine is an alkylating agent which also shows properties of a purine analog. Because of its unique mechanism of action it shows activity in relapsed indolent lymphomas which are resistant to alkylating agents, purine analogs, and rituximab. Bendamustine has a favorable toxicity profile causin...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2008
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2621381/ https://ncbi.nlm.nih.gov/pubmed/19209254 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|